Intrinsic Value of S&P & Nasdaq Contact Us

DURECT Corporation DRRX NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
46/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — DRRX

DURECT Corporation (DRRX) has a market capitalization of $59.31M and trades at $1.91. The 52-week range is 0.48-2.64.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.1, Earnings Per Share (EPS) of $-0.27, annual revenue of $2.03M.

The stock has a beta of 0.93, operates in the Healthcare sector.

Trading Data
Current Price$1.91
52-Week Range0.48-2.64
Volume2.14M
Avg Volume (30D)1.19M
Market Cap$59.31M
Beta (1Y)0.93
Company
IPO Date2000-09-28
Employees21
CEOJames E. Brown D.V.M.
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS2666055007
CUSIP266605104
Income (Latest Year)
Revenue$2.03M
Gross Profit$1.95M
EBITDA$-18.83M
Operating Income$-18.91M
Net Income$-8.32M
EPS$-0.27
EPS Diluted$-0.27
Shares Outstanding$30.94M
Balance Sheet (Latest Year)
Total Assets$18.35M
Current Assets$13.18M
Cash & ST Investments$11.8M
Total Liabilities$9.22M
Total Debt$2.21M
Net Debt$-8.81M
Total Equity$9.13M
Debt / Equity0.24
Valuation Ratios
P/E Ratio-7.1
P/S Ratio29.2
P/B Ratio6.5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message